BCL9 and cancer: To overcome the pharmaceutical obstacle of peptides in sensitizing cancer immunotherapy, Bcl9 peptides bridged Au1+ ions via Au–s bonds in a reducing environment to form a peptide Au precursor polymer as a shell which then self-assembled with GdOF to produce GdOFBAu via metal–organic coordination (Figure 1).